世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界および米国のAltretamine (CAS 645-05-6)市場の洞察、2027年までの予測

Global and United States Altretamine (CAS 645-05-6) Market Insights, Forecast to 2027

アルトレタミン（CAS 645-05-6）、C9H18N6、式重量は210.28で、水に不溶です。 Altretamineは、卵巣癌、SCLC、悪性リンパ腫、子宮内膜癌の併用化学療法に使用され、特に卵巣癌とSCLCに効果があります。市場... もっと見る

出版社	出版年月	電子版価格	納期	言語
QYResearch QYリサーチ	2021年11月12日	US$3,900 シングルユーザライセンスライセンス・価格情報注文方法はこちら	5-7営業日	英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

アルトレタミン（CAS 645-05-6）、C9H18N6、式重量は210.28で、水に不溶です。
Altretamineは、卵巣癌、SCLC、悪性リンパ腫、子宮内膜癌の併用化学療法に使用され、特に卵巣癌とSCLCに効果があります。

市場分析と洞察。世界および米国のAltretamine (CAS 645-05-6)市場
当レポートでは、世界および米国のAltretamine（CAS 645-05-6）市場に焦点を当てています。
2020年の世界のAltretamine (CAS 645-05-6)市場規模はXX百万米ドルで、2021年から2027年の間にXX％のCAGRで、2027年末までにXX百万米ドルに達すると予想されています。米国では、Altretamine (CAS 645-05-6)の市場規模は2020年のXX百万米ドルから2027年にはXX百万米ドルになり、予測期間中にXX%のCAGRで成長すると予測されています。

世界のAltretamine (CAS 645-05-6)の範囲と市場規模
Altretamine (CAS 645-05-6)の市場は、地域（国）別、プレイヤー別、タイプ別、アプリケーション別に分類されています。世界のAltretamine (CAS 645-05-6)市場に参加しているプレイヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして利用することで、優位に立つことができるでしょう。セグメント別分析では、2016年から2027年までの地域（国）別、タイプ別、アプリケーション別の収益と予測に焦点を当てています。
米国市場では、2016-2027年のAltretamine（CAS 645-05-6）の市場規模を、プレイヤー別、タイプ別、アプリケーション別に取り上げています。主要なプレイヤーには、アメリカ合衆国で重要な役割を果たす世界的なプレイヤーと地域のプレイヤーが含まれます。

タイプ別セグメント
カプセル
錠剤
腸溶性コーティング錠

用途別セグメント
病院薬剤師
小売薬局
オンライン薬局

地域別
北アメリカ
U.S.
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
アジアパシフィック
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中近東・アフリカ
トルコ
サウジアラビア
U.A.E.

会社名
Maoxiang Phrama
Zhongfu Phrama
Angsheng Pharma
Chiatai Pharma
Lisheng Pharma
アクティザ
ナットコ・ファーマ
エーザイ

ページTOPに戻る

1 Study Coverage
1.1 Altretamine (CAS 645-05-6) Product Introduction
1.2 Market by Type
1.2.1 Global Altretamine (CAS 645-05-6) Market Size Growth Rate by Type
1.2.2 Capsule
1.2.3 Tablet
1.2.4 Enteric Coated Tablet
1.3 Market by Application
1.3.1 Global Altretamine (CAS 645-05-6) Market Size Growth Rate by Application
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Altretamine (CAS 645-05-6) Market Size, Estimates and Forecasts
2.1.1 Global Altretamine (CAS 645-05-6) Revenue 2016-2027
2.1.2 Global Altretamine (CAS 645-05-6) Sales 2016-2027
2.2 Global Altretamine (CAS 645-05-6), Market Size by Region: 2016 VS 2021 VS 2027
2.3 Altretamine (CAS 645-05-6) Historical Market Size by Region (2016-2021)
2.3.1 Global Altretamine (CAS 645-05-6) Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Altretamine (CAS 645-05-6) Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Altretamine (CAS 645-05-6) Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Altretamine (CAS 645-05-6) Sales Forecast by Region (2022-2027)
2.4.2 Global Altretamine (CAS 645-05-6) Revenue Forecast by Region (2022-2027)

3 Global Altretamine (CAS 645-05-6) Competitor Landscape by Players
3.1 Global Top Altretamine (CAS 645-05-6) Manufacturers by Sales
3.1.1 Global Altretamine (CAS 645-05-6) Sales by Manufacturer (2016-2021)
3.1.2 Global Altretamine (CAS 645-05-6) Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Altretamine (CAS 645-05-6) Manufacturers by Revenue
3.2.1 Key Altretamine (CAS 645-05-6) Manufacturers Covered: Ranking by Revenue
3.2.2 Global Altretamine (CAS 645-05-6) Revenue by Manufacturers (2016-2021)
3.2.3 Global Altretamine (CAS 645-05-6) Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Altretamine (CAS 645-05-6) Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Altretamine (CAS 645-05-6) Revenue in 2020
3.2.6 Global Altretamine (CAS 645-05-6) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Altretamine (CAS 645-05-6) Price by Manufacturers
3.4 Global Altretamine (CAS 645-05-6) Manufacturing Base Distribution, Product Types
3.4.1 Altretamine (CAS 645-05-6) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Altretamine (CAS 645-05-6) Product Type
3.4.3 Date of International Manufacturers Enter into Altretamine (CAS 645-05-6) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Altretamine (CAS 645-05-6) Market Size by Type (2016-2021)
4.1.1 Global Altretamine (CAS 645-05-6) Sales by Type (2016-2021)
4.1.2 Global Altretamine (CAS 645-05-6) Revenue by Type (2016-2021)
4.1.3 Altretamine (CAS 645-05-6) Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Altretamine (CAS 645-05-6) Market Size Forecast by Type (2022-2027)
4.2.1 Global Altretamine (CAS 645-05-6) Sales Forecast by Type (2022-2027)
4.2.2 Global Altretamine (CAS 645-05-6) Revenue Forecast by Type (2022-2027)
4.2.3 Altretamine (CAS 645-05-6) Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Altretamine (CAS 645-05-6) Market Size by Application (2016-2021)
5.1.1 Global Altretamine (CAS 645-05-6) Sales by Application (2016-2021)
5.1.2 Global Altretamine (CAS 645-05-6) Revenue by Application (2016-2021)
5.1.3 Altretamine (CAS 645-05-6) Price by Application (2016-2021)
5.2 Altretamine (CAS 645-05-6) Market Size Forecast by Application (2022-2027)
5.2.1 Global Altretamine (CAS 645-05-6) Sales Forecast by Application (2022-2027)
5.2.2 Global Altretamine (CAS 645-05-6) Revenue Forecast by Application (2022-2027)
5.2.3 Global Altretamine (CAS 645-05-6) Price Forecast by Application (2022-2027)

6 United States by Players, Type and Application
6.1 United States Altretamine (CAS 645-05-6) Market Size YoY Growth 2016-2027
6.1.1 United States Altretamine (CAS 645-05-6) Sales YoY Growth 2016-2027
6.1.2 United States Altretamine (CAS 645-05-6) Revenue YoY Growth 2016-2027
6.1.3 United States Altretamine (CAS 645-05-6) Market Share in Global Market 2016-2027
6.2 United States Altretamine (CAS 645-05-6) Market Size by Players (International and Local Players)
6.2.1 United States Top Altretamine (CAS 645-05-6) Players by Sales (2016-2021)
6.2.2 United States Top Altretamine (CAS 645-05-6) Players by Revenue (2016-2021)
6.3 United States Altretamine (CAS 645-05-6) Historic Market Review by Type (2016-2021)
6.3.1 United States Altretamine (CAS 645-05-6) Sales Market Share by Type (2016-2021)
6.3.2 United States Altretamine (CAS 645-05-6) Revenue Market Share by Type (2016-2021)
6.3.3 United States Altretamine (CAS 645-05-6) Price by Type (2016-2021)
6.4 United States Altretamine (CAS 645-05-6) Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Altretamine (CAS 645-05-6) Sales Forecast by Type (2022-2027)
6.4.2 United States Altretamine (CAS 645-05-6) Revenue Forecast by Type (2022-2027)
6.4.3 United States Altretamine (CAS 645-05-6) Price Forecast by Type (2022-2027)
6.5 United States Altretamine (CAS 645-05-6) Historic Market Review by Application (2016-2021)
6.5.1 United States Altretamine (CAS 645-05-6) Sales Market Share by Application (2016-2021)
6.5.2 United States Altretamine (CAS 645-05-6) Revenue Market Share by Application (2016-2021)
6.5.3 United States Altretamine (CAS 645-05-6) Price by Application (2016-2021)
6.6 United States Altretamine (CAS 645-05-6) Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Altretamine (CAS 645-05-6) Sales Forecast by Application (2022-2027)
6.6.2 United States Altretamine (CAS 645-05-6) Revenue Forecast by Application (2022-2027)
6.6.3 United States Altretamine (CAS 645-05-6) Price Forecast by Application (2022-2027)

7 North America
7.1 North America Altretamine (CAS 645-05-6) Market Size YoY Growth 2016-2027
7.2 North America Altretamine (CAS 645-05-6) Market Facts & Figures by Country
7.2.1 North America Altretamine (CAS 645-05-6) Sales by Country (2016-2021)
7.2.2 North America Altretamine (CAS 645-05-6) Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Altretamine (CAS 645-05-6) Market Size YoY Growth 2016-2027
8.2 Asia Pacific Altretamine (CAS 645-05-6) Market Facts & Figures by Region
8.2.1 Asia Pacific Altretamine (CAS 645-05-6) Sales by Region (2016-2021)
8.2.2 Asia Pacific Altretamine (CAS 645-05-6) Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Altretamine (CAS 645-05-6) Market Size YoY Growth 2016-2027
9.2 Europe Altretamine (CAS 645-05-6) Market Facts & Figures by Country
9.2.1 Europe Altretamine (CAS 645-05-6) Sales by Country (2016-2021)
9.2.2 Europe Altretamine (CAS 645-05-6) Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Altretamine (CAS 645-05-6) Market Size YoY Growth 2016-2027
10.2 Latin America Altretamine (CAS 645-05-6) Market Facts & Figures by Country
10.2.1 Latin America Altretamine (CAS 645-05-6) Sales by Country (2016-2021)
10.2.2 Latin America Altretamine (CAS 645-05-6) Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Altretamine (CAS 645-05-6) Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Altretamine (CAS 645-05-6) Market Facts & Figures by Country
11.2.1 Middle East and Africa Altretamine (CAS 645-05-6) Sales by Country (2016-2021)
11.2.2 Middle East and Africa Altretamine (CAS 645-05-6) Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Maoxiang Phrama
12.1.1 Maoxiang Phrama Corporation Information
12.1.2 Maoxiang Phrama Description and Business Overview
12.1.3 Maoxiang Phrama Altretamine (CAS 645-05-6) Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Maoxiang Phrama Altretamine (CAS 645-05-6) Products Offered
12.1.5 Maoxiang Phrama Recent Development
12.2 Zhongfu Phrama
12.2.1 Zhongfu Phrama Corporation Information
12.2.2 Zhongfu Phrama Description and Business Overview
12.2.3 Zhongfu Phrama Altretamine (CAS 645-05-6) Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Zhongfu Phrama Altretamine (CAS 645-05-6) Products Offered
12.2.5 Zhongfu Phrama Recent Development
12.3 Angsheng Pharma
12.3.1 Angsheng Pharma Corporation Information
12.3.2 Angsheng Pharma Description and Business Overview
12.3.3 Angsheng Pharma Altretamine (CAS 645-05-6) Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Angsheng Pharma Altretamine (CAS 645-05-6) Products Offered
12.3.5 Angsheng Pharma Recent Development
12.4 Chiatai Pharma
12.4.1 Chiatai Pharma Corporation Information
12.4.2 Chiatai Pharma Description and Business Overview
12.4.3 Chiatai Pharma Altretamine (CAS 645-05-6) Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Chiatai Pharma Altretamine (CAS 645-05-6) Products Offered
12.4.5 Chiatai Pharma Recent Development
12.5 Lisheng Pharma
12.5.1 Lisheng Pharma Corporation Information
12.5.2 Lisheng Pharma Description and Business Overview
12.5.3 Lisheng Pharma Altretamine (CAS 645-05-6) Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Lisheng Pharma Altretamine (CAS 645-05-6) Products Offered
12.5.5 Lisheng Pharma Recent Development
12.6 Actiza
12.6.1 Actiza Corporation Information
12.6.2 Actiza Description and Business Overview
12.6.3 Actiza Altretamine (CAS 645-05-6) Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Actiza Altretamine (CAS 645-05-6) Products Offered
12.6.5 Actiza Recent Development
12.7 Natco Pharma
12.7.1 Natco Pharma Corporation Information
12.7.2 Natco Pharma Description and Business Overview
12.7.3 Natco Pharma Altretamine (CAS 645-05-6) Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Natco Pharma Altretamine (CAS 645-05-6) Products Offered
12.7.5 Natco Pharma Recent Development
12.8 Eisai
12.8.1 Eisai Corporation Information
12.8.2 Eisai Description and Business Overview
12.8.3 Eisai Altretamine (CAS 645-05-6) Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Eisai Altretamine (CAS 645-05-6) Products Offered
12.8.5 Eisai Recent Development
12.11 Maoxiang Phrama
12.11.1 Maoxiang Phrama Corporation Information
12.11.2 Maoxiang Phrama Description and Business Overview
12.11.3 Maoxiang Phrama Altretamine (CAS 645-05-6) Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Maoxiang Phrama Altretamine (CAS 645-05-6) Products Offered
12.11.5 Maoxiang Phrama Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Altretamine (CAS 645-05-6) Industry Trends
13.2 Altretamine (CAS 645-05-6) Market Drivers
13.3 Altretamine (CAS 645-05-6) Market Challenges
13.4 Altretamine (CAS 645-05-6) Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Altretamine (CAS 645-05-6) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

ページTOPに戻る

Table of Contents

Summary

Altretamine (CAS 645-05-6), C9H18N6, the formula weight is 210.28, and its insoluble in water.
Altretamine is used in combination chemotherapy for ovarian cancer, SCLC, malignant lymphoma and endometrial cancer, and is particularly effective for ovarian cancer and SCLC.

Market Analysis and Insights: Global and United States Altretamine (CAS 645-05-6) Market
This report focuses on global and United States Altretamine (CAS 645-05-6) market.
In 2020, the global Altretamine (CAS 645-05-6) market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In United States the Altretamine (CAS 645-05-6) market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Altretamine (CAS 645-05-6) Scope and Market Size
Altretamine (CAS 645-05-6) market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Altretamine (CAS 645-05-6) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For United States market, this report focuses on the Altretamine (CAS 645-05-6) market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in United States.

Segment by Type
Capsule
Tablet
Enteric Coated Tablet

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Maoxiang Phrama
Zhongfu Phrama
Angsheng Pharma
Chiatai Pharma
Lisheng Pharma
Actiza
Natco Pharma
Eisai

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

本レポートと同分野の最新刊レポートはありません。

QYResearch社の
Fatal error: Uncaught TypeError: Cannot access offset of type string on string in /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/58b4bde6a9738f3389cd7dea7f4ef5c62fdc6c54_0.file.auto_report.tpl.php:630 Stack trace: #0 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_resource_base.php(123): content_68d51da90169e8_18903235() #1 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_compiled.php(114): Smarty_Template_Resource_Base->getRenderedTemplateCode() #2 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(216): Smarty_Template_Compiled->render() #3 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(385): Smarty_Internal_Template->render() #4 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/f20300271f4eb0fb4a2cf788aaabb06be5646d19_0.file.frame-FULL.tpl.php(278): Smarty_Internal_Template->_subTemplateRender() #5 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_resource_base.php(123): content_68b0f61a4d9868_07068969() #6 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_compiled.php(114): Smarty_Template_Resource_Base->getRenderedTemplateCode() #7 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(216): Smarty_Template_Compiled->render() #8 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_templatebase.php(238): Smarty_Internal_Template->render() #9 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_templatebase.php(134): Smarty_Internal_TemplateBase->_execute() #10 /var/www/vhosts/dri.co.jp/httpdocs/auto/show_report.php(776): Smarty_Internal_TemplateBase->display() #11 {main} thrown in /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/58b4bde6a9738f3389cd7dea7f4ef5c62fdc6c54_0.file.auto_report.tpl.php on line 630

世界および米国のAltretamine (CAS 645-05-6)市場の洞察、2027年までの予測

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野の最新刊レポート